Mylan said a Florida administrative law judge ordered that the company's Levothyroxine Sodium product be removed from the state's negative drug formulary.When a drug is included on Florida's negative formulary, pharmacists can't substitute a generic version for a prescribed brand version. Last August, Mylan filed a petition challenging the validity of Levothyroxine's inclusion on the list. Abbott Lab, which makes a brand version of Levothyroxine Sodium, intervened. In a Jan. 28 order, Mylan's subsequent motion for summary final order was granted.
The Pittsburgh generic-drug maker said Friday it will make its products available to pharmacies in Florida as soon as motions and procedural steps are satisfied.
The Pittsburgh generic-drug maker said Friday it will make its products available to pharmacies in Florida as soon as motions and procedural steps are satisfied.
